Silencing Receptor EphA2 Enhanced Sensitivity to Lipoplatin™ in Lung Tumor and MPM Cells

Hung-Yen LeeDivision of Pulmonary, Critical Care & Sleep Medicine, Department of Medicine, University of Florida, Gainesville, FL, USA;Biomaterials Center, Department of Materials Sciences and Engineering, University of Florida, Gainesville, FL, USA

Kamal A. MohammedDivision of Pulmonary, Critical Care & Sleep Medicine, Department of Medicine, University of Florida, Gainesville, FL, USA;NF/SGVHS, Malcom Randall VA Medical Center, University of Florida, Gainesville, FL, USA

Eugene P. GoldbergBiomaterials Center, Department of Materials Sciences and Engineering, University of Florida, Gainesville, FL, USA

Frederic KayeDepartment of Hematology and Oncology, University of Florida, Gainesville, FL, USA

Najmunnisa NasreenDivision of Pulmonary, Critical Care & Sleep Medicine, Department of Medicine, University of Florida, Gainesville, FL, USA;NF/SGVHS, Malcom Randall VA Medical Center, University of Florida, Gainesville, FL, USACorrespondence[email protected]

Silencing Receptor EphA2 Enhanced Sensitivity to Lipoplatin™ in Lung Tumor and MPM Cells

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Silencing Receptor EphA2 Enhanced Sensitivity to Lipoplatin™ in Lung Tumor and MPM Cells

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date